BioCryst Pharmaceuticals | Capitale Ordinario



Ordinary Share Capital Cambiamento Data
Alnylam Pharmaceuticals USD 1.3M 10K 2025-03
Chugai Pharma JPY 73.2B 0 2024-09
Daiichi Sankyo JPY 50B 0 2025-03
DBV Technologies USD 11.65M 1000 2025-03
Gilead Sciences USD 1000K 0 2024-12
GlaxoSmithKline GBP 1.35B 1000K 2025-03
Glaxosmithkline GBP 1.35B 0 2024-12
Incyte USD 193K 0 2025-03
Ionis Pharmaceuticals USD 159K 1000 2025-03
Neurocrine Biosciences USD 100K 0 2024-12
PTC Therapeutics USD 78K 1000 2025-03
Regeneron Pharmaceuticals USD 0 102K 2025-03
Roche Holding CHF 107M 0 2024-06
Sarepta Therapeutics USD 10K 0 2025-03
Ultragenyx Pharmaceutical USD 92K 0 2024-12
Vertex Pharmaceuticals USD 2.6M 0 2024-12



BioCryst Pharmaceuticals Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.